About Dr. Amita Naithani

• Dr. Amita Naithani is a highly respected Gynae Oncologist with over 16 years of extensive experience in the management of gynecologic cancers.
• She is known for her expertise in advanced cytoreductive ovarian cancer surgeries, especially in cases involving recurrent or metastatic disease.
• Her surgical proficiency includes HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and HITHOC (Hyperthermic Intrathoracic Chemotherapy), offering state-of-the-art treatment to women with advanced cancers.
• Dr. Naithani is a DaVinci-certified Robotic Console Surgeon, skilled in both open and robotic techniques for performing radical hysterectomy, radical vulvectomy, and inguinal lymph node dissections.
• She has treated over 15,000 women cancer patients and performed more than 1,000 robotic surgeries, establishing herself as one of India’s leading specialists in her field.
• Dr. Naithani’s foundational training began at Lady Hardinge Medical College & Kalawati Saran Children’s Hospital, where she completed her MBBS and DGO.
• She pursued her DNB in Obstetrics & Gynaecology from St. Stephen’s Hospital, New Delhi, and later completed her Fellowship in Gynecologic Oncology at the Rajiv Gandhi Cancer Institute, one of India’s leading cancer centers.
• She also received certification in robotic surgery from Intuitive Surgical through the same institution.
• Before joining Artemis, Dr. Naithani served for over a decade at Rajiv Gandhi Cancer Institute, where she played a key role in developing comprehensive gynecologic cancer care services.
• She also worked at Max Cancer Centre, Sir Ganga Ram Hospital, and Jaipur Golden Hospital, gaining valuable experience in high-volume, multidisciplinary oncology environments.
• An academic at heart, Dr. Naithani has authored multiple scientific papers, contributed to oncology education, and regularly presents at national and international conferences.
• She is actively involved in teaching and clinical research and is a known voice in various medical societies dedicated to gynecologic oncology.